255 related articles for article (PubMed ID: 23973042)
1. Targeting the unstable plaque in acute coronary syndromes.
Thompson PL; Nidorf SM; Eikelboom J
Clin Ther; 2013 Aug; 35(8):1099-107. PubMed ID: 23973042
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic Role of Innovative Anti-Inflammatory Medications in the Prevention of Acute Coronary Syndrome.
Pashun RA; Frishman WH
Cardiol Rev; 2015; 23(5):252-60. PubMed ID: 25741604
[TBL] [Abstract][Full Text] [Related]
3. Update on the efficacy of statin treatment in acute coronary syndromes.
Rosa GM; Carbone F; Parodi A; Massimelli EA; Brunelli C; Mach F; Vuilleumier N; Montecucco F
Eur J Clin Invest; 2014 May; 44(5):501-15. PubMed ID: 24601937
[TBL] [Abstract][Full Text] [Related]
4. Update on acute coronary syndromes: the pathologists' view.
Falk E; Nakano M; Bentzon JF; Finn AV; Virmani R
Eur Heart J; 2013 Mar; 34(10):719-28. PubMed ID: 23242196
[TBL] [Abstract][Full Text] [Related]
5. [Stabilization of vulnerable coronary plaque].
Chibana H; Mitsutake Y; Itaya N; Ueno T
Nihon Rinsho; 2011 Nov; 69 Suppl 9():306-10. PubMed ID: 22724220
[No Abstract] [Full Text] [Related]
6. HMG-CoA reductase inhibitor (Statin) therapy and coronary atherosclerosis in Japanese subjects: role of high-density lipoprotein cholesterol.
Tani S; Nagao K; Hirayama A
Am J Cardiovasc Drugs; 2011 Dec; 11(6):411-7. PubMed ID: 22149320
[TBL] [Abstract][Full Text] [Related]
7. A novel mouse model of atherosclerotic plaque instability for drug testing and mechanistic/therapeutic discoveries using gene and microRNA expression profiling.
Chen YC; Bui AV; Diesch J; Manasseh R; Hausding C; Rivera J; Haviv I; Agrotis A; Htun NM; Jowett J; Hagemeyer CE; Hannan RD; Bobik A; Peter K
Circ Res; 2013 Jul; 113(3):252-65. PubMed ID: 23748430
[TBL] [Abstract][Full Text] [Related]
8. The Beneficial Therapy with Colchicine for Atherosclerosis via Anti-inflammation and Decrease in Hypertriglyceridemia.
Spartalis M; Spartalis E; Tzatzaki E; Tsilimigras DI; Moris D; Kontogiannis C; Kaminiotis VV; Paschou SA; Chatzidou S; Siasos G; Voudris V; Iliopoulos DC
Cardiovasc Hematol Agents Med Chem; 2018; 16(2):74-80. PubMed ID: 30526472
[TBL] [Abstract][Full Text] [Related]
9. Cholesterol crystals piercing the arterial plaque and intima trigger local and systemic inflammation.
Abela GS
J Clin Lipidol; 2010; 4(3):156-64. PubMed ID: 21122648
[TBL] [Abstract][Full Text] [Related]
10. Statin loading for acute coronary syndromes.
Nusca A; Melfi R; Patti G; Di Sciascio G
Curr Opin Cardiol; 2010 Jul; 25(4):373-8. PubMed ID: 20520540
[TBL] [Abstract][Full Text] [Related]
11. Clinical value of drugs targeting inflammation for the management of coronary artery disease.
Duchatelle V; Kritikou EA; Tardif JC
Can J Cardiol; 2012; 28(6):678-86. PubMed ID: 22926034
[TBL] [Abstract][Full Text] [Related]
12. Targeting cholesterol crystal-induced inflammation for the secondary prevention of cardiovascular disease.
Nidorf SM; Eikelboom JW; Thompson PL
J Cardiovasc Pharmacol Ther; 2014 Jan; 19(1):45-52. PubMed ID: 24038016
[TBL] [Abstract][Full Text] [Related]
13. Plaque regression and improved clinical outcomes following statin treatment in atherosclerosis.
Girotra S; Murarka S; Migrino RQ
Panminerva Med; 2012 Jun; 54(2):71-81. PubMed ID: 22525562
[TBL] [Abstract][Full Text] [Related]
14. Inflammation and beyond: new directions and emerging drugs for treating atherosclerosis.
Bertrand MJ; Tardif JC
Expert Opin Emerg Drugs; 2017 Mar; 22(1):1-26. PubMed ID: 27927063
[TBL] [Abstract][Full Text] [Related]
15. The ezetimibe controversy: implications for clinical practice.
Khanderia U; Regal RE; Rubenfire M; Boyden T
Ther Adv Cardiovasc Dis; 2011 Aug; 5(4):199-208. PubMed ID: 21636623
[TBL] [Abstract][Full Text] [Related]
16. The Role of Colchicine in Acute Coronary Syndromes.
Vaidya K; Martínez G; Patel S
Clin Ther; 2019 Jan; 41(1):11-20. PubMed ID: 30185392
[TBL] [Abstract][Full Text] [Related]
17. [The promise of statins].
Capurso A
Ital Heart J Suppl; 2001 Mar; 2(3):224-9. PubMed ID: 11307780
[TBL] [Abstract][Full Text] [Related]
18. Plaque regression and progenitor cell mobilization with intensive lipid elimination regimen (PREMIER) trial design.
Banerjee S; Abu Fadel M; Sarode R; Terada L; Moritz T; Luo P; Hastings J; Brilakis ES; Reda D
J Clin Apher; 2014 Apr; 29(2):97-106. PubMed ID: 24123098
[TBL] [Abstract][Full Text] [Related]
19. [Does Lp-PLA2 determination help predict atherosclerosis and cardiocerebrovascular disease?].
Sertić J; Skorić B; Lovrić J; Bozina T; Reiner Z
Acta Med Croatica; 2010 Oct; 64(4):237-45. PubMed ID: 21688606
[TBL] [Abstract][Full Text] [Related]
20. Colchicine in Stable Coronary Artery Disease.
Fiolet ATL; Nidorf SM; Mosterd A; Cornel JH
Clin Ther; 2019 Jan; 41(1):30-40. PubMed ID: 30396516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
